GLSI
Price
$26.26
Change
-$0.75 (-2.78%)
Updated
Feb 5, 01:47 PM (EDT)
Capitalization
375.18M
20 days until earnings call
Intraday BUY SELL Signals
IBRX
Price
$5.88
Change
-$0.45 (-7.11%)
Updated
Feb 4 closing price
Capitalization
5.79B
26 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GLSI vs IBRX

Header iconGLSI vs IBRX Comparison
Open Charts GLSI vs IBRXBanner chart's image
Greenwich LifeSciences
Price$26.26
Change-$0.75 (-2.78%)
Volume$100
Capitalization375.18M
ImmunityBio
Price$5.88
Change-$0.45 (-7.11%)
Volume$21.45M
Capitalization5.79B
GLSI vs IBRX Comparison Chart in %
GLSI
Daily Signal:
Gain/Loss:
IBRX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
GLSI vs. IBRX commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLSI is a Hold and IBRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (GLSI: $27.01 vs. IBRX: $5.88)
Brand notoriety: GLSI and IBRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLSI: 39% vs. IBRX: 68%
Market capitalization -- GLSI: $375.18M vs. IBRX: $5.79B
GLSI [@Biotechnology] is valued at $375.18M. IBRX’s [@Biotechnology] market capitalization is $5.79B. The market cap for tickers in the [@Biotechnology] industry ranges from $119.38B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLSI’s FA Score shows that 0 FA rating(s) are green whileIBRX’s FA Score has 1 green FA rating(s).

  • GLSI’s FA Score: 0 green, 5 red.
  • IBRX’s FA Score: 1 green, 4 red.
According to our system of comparison, IBRX is a better buy in the long-term than GLSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLSI’s TA Score shows that 4 TA indicator(s) are bullish while IBRX’s TA Score has 6 bullish TA indicator(s).

  • GLSI’s TA Score: 4 bullish, 5 bearish.
  • IBRX’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, IBRX is a better buy in the short-term than GLSI.

Price Growth

GLSI (@Biotechnology) experienced а -5.53% price change this week, while IBRX (@Biotechnology) price change was -4.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.81%. For the same industry, the average monthly price growth was +0.47%, and the average quarterly price growth was +32.90%.

Reported Earning Dates

GLSI is expected to report earnings on Feb 25, 2026.

IBRX is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (-3.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IBRX($5.79B) has a higher market cap than GLSI($375M). IBRX YTD gains are higher at: 196.970 vs. GLSI (28.558). GLSI has higher annual earnings (EBITDA): -19.58M vs. IBRX (-232.66M). IBRX has more cash in the bank: 258M vs. GLSI (3.81M). IBRX has higher revenues than GLSI: IBRX (82.6M) vs GLSI (0).
GLSIIBRXGLSI / IBRX
Capitalization375M5.79B6%
EBITDA-19.58M-232.66M8%
Gain YTD28.558196.97014%
P/E RatioN/AN/A-
Revenue082.6M-
Total Cash3.81M258M1%
Total DebtN/A542M-
FUNDAMENTALS RATINGS
IBRX: Fundamental Ratings
IBRX
OUTLOOK RATING
1..100
24
VALUATION
overvalued / fair valued / undervalued
1..100
3
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLSIIBRX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 15 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
GLSI
Daily Signal:
Gain/Loss:
IBRX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IMCVX9.700.13
+1.36%
Voya Multi-Manager Mid Cap Value I
WFSAX27.09N/A
N/A
Allspring Small Company Growth A
PXXLF0.25N/A
N/A
Poxel SA
SPGIX37.32-0.51
-1.35%
SEI Large Cap Growth I (SIMT)
PWJQX34.67-0.63
-1.78%
PGIM Jennison International Opps R6

IBRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IBRX has been closely correlated with ACET. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if IBRX jumps, then ACET could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IBRX
1D Price
Change %
IBRX100%
-7.11%
ACET - IBRX
72%
Closely correlated
-3.51%
GLSI - IBRX
71%
Closely correlated
-3.62%
INBX - IBRX
69%
Closely correlated
-2.96%
PMN - IBRX
68%
Closely correlated
-1.57%
ANL - IBRX
67%
Closely correlated
+7.23%
More